BDX

Becton Dickinson and Company
251.82
2.68 (1.08%)
Upgrade to Real-Time
Afterhours (Closed)
251.82
Volume 1,230,934
Bid Price
Ask Price
News -
Day High 253.38

Low
215.90

52 Week Range

High
280.62

Day Low 248.13
Company Name Stock Ticker Symbol Market Type
Becton Dickinson and Company BDX NYSE Common Stock
  Price Change Change Percent Stock Price Last Traded
2.68 1.08% 251.82 16:59:49
Open Price Low Price High Price Close Price Prev Close
249.29 248.13 253.38 251.82 249.14
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
25,271 1,230,934 $ 251.68 $ 309,802,454 - 215.90 - 280.62
Last Trade Time Type Quantity Stock Price Currency
19:00:00 115,188 $ 251.82 USD

Period:

Draw Mode:

Becton Dickinson and Company Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 71.58B 284.27M 283.92M $ 19.41B $ 1.59B 5.89 41.90
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ 3.48 1.46% 03/09/23 191.81k 0.50%

more financials information »

Becton Dickinson News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical BDX Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week255.11255.11242.72248.89957,355-3.29-1.29%
1 Month255.81262.66242.72253.931,075,418-3.99-1.56%
3 Months224.07262.66217.70241.871,378,35627.7512.38%
6 Months243.54269.06215.90241.451,230,9068.283.4%
1 Year254.37280.62215.90249.231,209,802-2.55-1.0%
3 Years274.00286.72197.75246.531,470,991-22.18-8.09%
5 Years246.30286.72197.75244.991,324,0215.522.24%

Becton Dickinson Description

Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Interventional (largely the former Bard business) accounts for 24% of revenue. International revenue accounts for 43% of the company's business.